Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular respiration is a fundamental metabolic pathway in which cells convert biochemical energy from nutrients, primarily glucose, into adenosine triphosphate (ATP), the main energy currency of the cell. In eukaryotic cells, most ATP production occurs within mitochondria through a series of tightly regulated biochemical processes. The process consists of glycolysis, pyruvate oxidation, citric acid cycle, and oxidative phosphorylation. The electron transport chain uses electrons from NADH/FADH₂ to pump protons across membrane creating an electrochemical gradient, which drives ATP synthase to synthesize ATP from ADP + Pi.
Varies depending on the specific drug or inhibitor; examples include disrupting the proton gradient, blocking electron transfer, or directly inhibiting ATP synthase.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular Respiration (Mitochondrial ATP Production).